The Charleston Conference on Alzheimer's Disease (CCAD) was developed in 2012 by a conference of researchers and philanthropists in response to the growing public health problem of understanding and treating Alzheimer's disease.
The ﬁrst conference took place in March, 2013. Established scientists joined early career investigators who proposed novel research ideas. A select few early career investigators were awarded ﬁnancial support for their proposals through the New Vision Awards. The New Vision Awards demonstrate CCAD's continued encouragement for young investigators, appreciation for innovative and collaborative approaches to research, and hope to change the trajectory of Alzheimer's disease research.
In addition to ﬁnancially supporting early career investigators through the New Vision Awards, CCAD also oﬀered a unique opportunity for investigators of different career levels and ﬁelds (genetics, neuroimaging, cell biology, etc.) to network and collaborate.